Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells Exosomes for the Treatment of Trigeminal Neuralgia
Who is this study for? Patients with Peripheral Neuropathy, Trigeminal Neuralgia
What treatments are being studied? AlloRx
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
This trial will study the safety and efficacy of instillation of cultured allogeneic adult umbilical cord derived mesenchymal stem cell exosomes for the treatment of Trigeminal Neuralgia.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Diagnosis of Trigeminal Neuralgia or Peripheral Neuropathy
• Understanding and willingness to sign a written informed consent document
Locations
Other Locations
Antigua and Barbuda
Medical Surgical Associates Center
RECRUITING
St John's
Time Frame
Start Date: 2022-09-09
Estimated Completion Date: 2026-01
Participants
Target number of participants: 20
Treatments
Experimental: Treatment Group (AlloEx)
Intranasal installation of 4 CCs of AlloEx, which is approximately 800 billion exosomes.
Related Therapeutic Areas
Sponsors
Leads: The Foundation for Orthopaedics and Regenerative Medicine